EPS Bio Technology Corp. (TPEX:4183)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
14.00
+0.55 (4.09%)
May 8, 2026, 12:59 PM CST

EPS Bio Technology Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-21.34-7.8717.3120.9925.3618.64
Depreciation & Amortization
15.815.1114.1814.916.6217.85
Other Amortization
0.270.270.420.60.690.73
Loss (Gain) From Sale of Assets
00-0.26--
Provision & Write-off of Bad Debts
3.372.6-1.890.162.611.2
Other Operating Activities
3.41-0.99-15.525.45-10.337.63
Change in Accounts Receivable
22.92-3.35-51.18-17.0820.8-21.49
Change in Inventory
-7.467.17-8.3910.86-4.89-35.46
Change in Accounts Payable
-36.25-7.855.8416.42-23.1524.82
Change in Unearned Revenue
-11.49-5.379.963.97-27.6922.7
Change in Other Net Operating Assets
2.780.87-3.07-1.354.98-4.54
Operating Cash Flow
-28.120.6-32.3455.17532.08
Operating Cash Flow Growth
---1003.86%-84.42%-59.85%
Capital Expenditures
-17.38-22.36-13.9-9.48-14.95-11.75
Sale of Property, Plant & Equipment
--0.01---
Sale (Purchase) of Intangibles
-1.61-1.61-0.51---0.39
Other Investing Activities
----0.04-
Investing Cash Flow
-18.98-23.97-14.4-9.48-14.92-12.14
Short-Term Debt Issued
-50----
Total Debt Issued
9050----
Short-Term Debt Repaid
--10----
Long-Term Debt Repaid
--6.06-5.68-5.59-5.93-5.46
Total Debt Repaid
-56.09-16.06-5.68-5.59-5.93-5.46
Net Debt Issued (Repaid)
33.9233.94-5.68-5.59-5.93-5.46
Common Dividends Paid
-15.95-15.95-19.04-23.32-16.66-28.56
Financing Cash Flow
17.9718-24.72-28.91-22.59-34.02
Foreign Exchange Rate Adjustments
-1.12-0.495.11-0.157.75-4.38
Net Cash Flow
-30.25-5.86-66.3516.63-24.76-18.45
Free Cash Flow
-45.5-21.76-46.2445.69-9.9620.34
Free Cash Flow Growth
------72.30%
Free Cash Flow Margin
-10.26%-4.35%-10.25%9.72%-2.15%4.23%
Free Cash Flow Per Share
-1.91-0.91-1.941.91-0.420.85
Cash Interest Paid
1.91.92.052.142.132.18
Cash Income Tax Paid
0.640.646.596.483.774.32
Levered Free Cash Flow
--24.01-60.9839.95-22.3115.26
Unlevered Free Cash Flow
--22.82-59.741.29-20.9816.63
Change in Working Capital
-29.5-8.53-46.8412.82-29.94-13.96
Source: S&P Global Market Intelligence. Standard template. Financial Sources.